Apotex Execs Avoid Criminal Charges Under DOJ Deferred Prosecution Agreement

 
• By Brenda Sandburg

While former Sandoz and Heritage execs were charged in the government's generic price-fixing probe, Apotex and its employees will apparently escape such fate if they abide by the terms of DOJ agreement; company admits to fixing price of pravastatin and agrees to pay $24.1m criminal penalty.

WASHINGTON, DC - MARCH 2018: Headquarters of the U.S. Justice Department. Art Deco aluminum torcheres at doorway. Renamed the Robert F. Kennedy Department of Justice Building in 2001.
DOJ charges fourth company in generic pricing probe and defers prosecution

More from Generics

More from Biosimilars & Generics